Published in J Exp Med on March 01, 1988
Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene. J Exp Med (1990) 2.98
Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest (1992) 1.46
The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J Exp Med (1997) 1.39
Protein evolution on rugged landscapes. Proc Natl Acad Sci U S A (1989) 1.37
Evolution of antibody structure during the immune response. The differentiative potential of a single B lymphocyte. J Exp Med (1989) 1.26
Heavy-chain class switch does not terminate somatic mutation. J Exp Med (1990) 1.16
Somatic immunoglobulin hypermutation. Curr Opin Immunol (2002) 1.14
Somatic mutation in constant regions of mouse lambda 1 light chains. Proc Natl Acad Sci U S A (1991) 1.08
Somatic hypermutation of an immunoglobulin mu heavy chain transgene. J Exp Med (1993) 1.04
Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism. Proc Natl Acad Sci U S A (1989) 1.01
Isolation of germinal centerlike events from human spleen RNA. Somatic hypermutation of a clonally related VH6DJH rearrangement expressed with IgM, IgG, and IgA. J Clin Invest (1993) 0.92
Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism. J Exp Med (1992) 0.88
Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J (1995) 0.86
Somatic generation of hybrid antibody H chain genes in transgenic mice via interchromosomal gene conversion. J Exp Med (1994) 0.85
Germ line variable regions that match hypermutated sequences in genes encoding murine anti-hapten antibodies. Genetics (1992) 0.82
Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2. J Exp Med (1994) 0.81
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Somatic generation of antibody diversity. Nature (1983) 28.06
Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature (1980) 10.19
Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell (1980) 8.77
The nucleotide sequence of a 5.5-kilobase DNA segment containing the mouse kappa immunoglobulin J and C region genes. J Biol Chem (1981) 7.26
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell (1981) 5.87
Variability in the lambda light chain sequences of mouse antibody. Nature (1970) 5.71
Complete nucleotide sequence of mouse immunoglobulin mu gene and comparison with other immunoglobulin heavy chain genes. Nucleic Acids Res (1980) 5.20
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94
Antibody diversity: somatic hypermutation of rearranged VH genes. Cell (1981) 4.65
Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature (1984) 4.45
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell (1987) 4.23
Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev (1987) 4.16
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54
Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A (1984) 3.35
Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24
Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6. Proc Natl Acad Sci U S A (1986) 3.15
Somatic mutation of immunoglobulin light-chain variable-region genes. Cell (1981) 3.06
Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst (1972) 3.01
A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature (1986) 2.83
Sequence homology requirements for intermolecular recombination in mammalian cells. Proc Natl Acad Sci U S A (1986) 2.50
Clusters of point mutations are found exclusively around rearranged antibody variable genes. Proc Natl Acad Sci U S A (1983) 2.38
The complete nucleotide sequence of mouse immunoglobin gamma 2a gene and evolution of heavy chain genes: further evidence for intervening sequence-mediated domain transfer. Nucleic Acids Res (1981) 2.26
Recombination between antibody heavy chain variable-region genes: evidence for gene conversion. Proc Natl Acad Sci U S A (1983) 2.03
Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med (1974) 2.02
VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J (1984) 1.98
Evolution of antibody variable region structure during the immune response. Immunol Rev (1987) 1.77
J genes for heavy chain immunoglobulins of mouse. Science (1980) 1.65
Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell (1981) 1.60
One heavy chain variable region gene segment subfamily in the BALB/c mouse contains 500-1000 or more members. Cell (1986) 1.60
The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol (1984) 1.59
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol Immunol (1984) 1.33
Restriction in IgM expression. IV. Affinity analysis of monoclonal anti-phosphorylcholine antibodies. J Immunol (1983) 1.30
The identification of monoclonal class switch variants by sib selection and an ELISA assay. J Immunol Methods (1984) 1.21
Somatic mutation in anti-phosphorylcholine antibodies. Immunol Rev (1987) 1.20
The sequence at the 3' terminus of mouse immunoglobulin secreted mu chain messenger RNA determined from cloned cDNA. Nucleic Acids Res (1980) 1.13
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol (1982) 1.04
Phosphorylcholine-binding hybridoma proteins of normal and idiotypically suppressed BALB/c mice I. Characterization and idiotypic analysis. Eur J Immunol (1980) 1.02
Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression. J Immunol (1986) 1.00
Somatically generated mouse myeloma variants synthesizing IgA half-molecules. J Exp Med (1981) 0.97
Highly preferential VH-VL pairing in normal B cells results in antigen-independent selection of the available repertoire. J Immunol (1987) 0.96
A sedimentation equilibrium method for determining molecular weights of proteins with a tabletop high speed air turbine centrifuge. J Biol Chem (1978) 0.93
The immune response of BALB/c mice to phosphorylcholine is restricted to a limited number of VH- and VL-isotypes. Mol Immunol (1981) 0.90
Phosphorylcholine-binding hybridoma proteins of normal and idiotypically suppressed BALB/c mice II. Variable region N-terminal amino acid sequences. Eur J Immunol (1980) 0.88
Immunologic memory to phosphocholine. V. Hybridomas representative of group II antibodies utilize V kappa 1-3 gene(s). J Immunol (1984) 0.85
Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes. J Immunol (1984) 0.84
Immunoglobulin heavy chain class switch from IgM to IgG in a hybridoma. Eur J Immunol (1983) 0.84
The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase. J Immunol (1983) 0.82
Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments. J Immunol (1984) 0.82
Lack of expression of the VHS107 gene family in the lipopolysaccharide-sensitive B cell subset of X-linked immunodeficiency-defective mice. J Exp Med (1986) 0.80
Paucity of phosphorylcholine-specific clones in B cells expressing the VHT15 gene product. J Exp Med (1986) 0.79
Ligand-affinity sedimentation equilibrium using an air-driven ultracentrifuge. Arch Biochem Biophys (1980) 0.77
Antibody diversity. New mechanism revealed. Nature (1986) 0.77
The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology (1968) 7.42
A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J Exp Med (1970) 4.26
The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion. Virology (1968) 4.19
Rapidly labeled, polyribosome-associated RNA having the properties of histone messenger. Proc Natl Acad Sci U S A (1967) 4.12
Rate of somatic mutation in immunoglobulin production by mouse myeloma cells. Proc Natl Acad Sci U S A (1971) 3.83
Preparation of mammalian polyribosomes with the detergent Nonidet P-40. Biochim Biophys Acta (1967) 3.81
Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma (1981) 3.58
Polyribosomal synthesis and assembly of the H and L chains of gamma globulin. Proc Natl Acad Sci U S A (1966) 3.53
Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A (1984) 3.35
Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun (1992) 3.21
Somatic cell hybridization of mouse myeloma cells. Cell (1976) 3.17
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods (1992) 2.97
Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell (1997) 2.78
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
The role of somatic hypermutation in the generation of antibody diversity. Science (1989) 2.55
The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38
Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion. Virology (1969) 2.27
The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med (1991) 2.11
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med (1995) 2.11
Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med (1993) 2.09
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol (1992) 2.06
Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci U S A (1977) 2.04
The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol (1992) 2.02
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother (1994) 2.00
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A (1975) 1.87
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A (1993) 1.86
Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis (1995) 1.86
Isolation of scid pre-B cells that rearrange kappa light chain genes: formation of normal signal and abnormal coding joins. EMBO J (1989) 1.86
Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med (2000) 1.82
Immunoglobulin production: method for quantitatively detecting variant myeloma cells. Science (1970) 1.81
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
The polypeptides of adenovirus. 3. Synthesis in infected cells. Virology (1969) 1.77
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci U S A (1997) 1.72
Synthesis of ribosomal RNA in synchronized HeLa cells. Nature (1965) 1.69
Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol (1995) 1.67
Synthesis of excess light chains of gamma globulin by rabbit lymph node cells. Nature (1966) 1.66
Variants of mouse myeloma cells that produce short immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1974) 1.66
Polyribosome disaggregation during metaphase. Science (1966) 1.61
Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61
Effect of adenovirus on host cell DNA synthesis in synchronized cells. Virology (1969) 1.61
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med (1997) 1.60
Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell (1981) 1.60
Synthesis of a carboxyl-terminal (constant region) fragment of the immunoglobulin light chain by a mouse myeloma cell line. J Mol Biol (1974) 1.54
Suppression of immunoglobulin synthesis by cellular hybridization. Nat New Biol (1971) 1.50
Antigen-non-specific T-cell factor in B-cell activation. Origin, biological properties and failure to show a relationship to H-2. Immunology (1976) 1.49
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J Mol Biol (1996) 1.41
Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother (1994) 1.41
Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39
Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol (2001) 1.36
IgG2a-producing variants of an IgG2b-producing mouse myeloma cell line. J Exp Med (1978) 1.34
Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol Immunol (1984) 1.33
Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun (2001) 1.32
IgG1 and IgG2b share the Fc receptor on mouse macrophages. J Immunol (1980) 1.31
Fusion of mouse myeloma and spleen cells. Curr Top Microbiol Immunol (1978) 1.30
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
Identification of rare immunoglobulin switch variants using the ELISA spot assay. J Immunol Methods (1992) 1.28
Mutagenesis of mouse myeloma cells with 'Melphalan'. Nature (1973) 1.27
Error-prone candidates vie for somatic mutation. J Exp Med (2000) 1.27
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med (1971) 1.27
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines. J Immunol (1973) 1.26
Role of antigen structure in the discrimination between tolerance and immunity by b cells. Transplant Rev (1975) 1.25
Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med (1998) 1.24
Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing gamma-chains and light chains. J Exp Med (1970) 1.23
Characterization of light chain and light chain constant region fragment mRNAs in MPC 11 mouse myeloma cells and variants. Cell (1975) 1.22
The identification of monoclonal class switch variants by sib selection and an ELISA assay. J Immunol Methods (1984) 1.21
Temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral peptides. Virology (1972) 1.20
The absence of a detectable G1 phase in a cultured strain of Chinese hamster lung cell. J Cell Biol (1967) 1.20
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J Exp Med (1996) 1.19
Persistence of messenger RNA through mitosis in HeLa cells. J Cell Biol (1969) 1.19
Synthesis, assembly and secretion of mouse immunoglobulin. Transplant Rev (1973) 1.19
Monoclonal antibodies: a powerful new tool in biology and medicine. Annu Rev Biochem (1981) 1.19
Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect Immun (1998) 1.14
Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation. Proc Natl Acad Sci U S A (2001) 1.12
Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB x NZW)F1 mice. J Exp Med (1991) 1.10
Mutations affecting antigenic determinants of an outer membrane protein of Escherichia coli. EMBO J (1986) 1.10
Synthesis and assembly of immunoglobulins by malignant human plasmacytes and lymphocytes. II. Heterogeneity of assembly in cells producing IgM proteins. J Exp Med (1971) 1.09
Mechanisms of gamma-globulin synthesis. J Immunol (1966) 1.08
Monoclonal antibodies. A new technique for producing serologic reagents. N Engl J Med (1981) 1.08
Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect Immun (1995) 1.08
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol (2000) 1.07
Characteristics of cultured lens epithelium. Invest Ophthalmol (1969) 1.07
Somatic diversification of the S107 (T15) VH11 germ-line gene that encodes the heavy-chain variable region of antibodies to double-stranded DNA in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A (1988) 1.07
Equivalent responsiveness to branched polysaccharides and their dinitrophenyl conjugates in the Biozzi high and low responder lines of mice. Eur J Immunol (1974) 1.07
Monoclonal antibodies reveal the structural basis of antibody diversity. Science (1983) 1.06
Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region. Proc Natl Acad Sci U S A (1987) 1.05
Mutant monoclonal antibodies with alterations in biological functions. J Exp Med (1982) 1.05